Odyssey Health (ODYY) Net Cash Flow Growth (1y) (2015 - 2026)
Odyssey Health (ODYY) Net Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn | 76.43% |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | -7,861.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -7,861.03% |
| Jan 31, 2026 | 1,365.57% |
| Oct 31, 2025 | -87.37% |
| Jul 31, 2025 | 124.98% |
| Apr 30, 2025 | 96.00% |
| Jan 31, 2025 | -47.05% |
| Oct 31, 2024 | -68.02% |
| Jul 31, 2024 | -278.59% |
| Apr 30, 2024 | -189.73% |
| Jan 31, 2024 | -115.83% |
| Oct 31, 2023 | 830.73% |
| Jul 31, 2023 | -83.76% |
| Apr 30, 2023 | -125.61% |
| Jan 31, 2023 | 95.67% |
| Oct 31, 2022 | 74.21% |
| Jul 31, 2022 | 112.51% |
| Apr 30, 2022 | -89.74% |
| Jan 31, 2022 | -47.94% |
| Oct 31, 2021 | -137.18% |
| Jul 31, 2021 | -4,930.91% |